Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Daily News

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Yael L. Maxwell

May 06, 2022

News Opinion CV Team Dispatch

January 2021 News Roundup

L.A. McKeown

January 01, 2021

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Caitlin E. Cox

April 23, 2020

News Daily News

Acute MI Quality Improvement Program Fails in India, but Researchers See Bright Side

L.A. McKeown

February 15, 2018

News Daily News

Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients

Yael L. Maxwell

November 04, 2015

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

News Industry News

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

June 05, 2015

News Daily News

High-Risk Acute MI Patients Less Likely to Stay on Guideline-Recommended Therapies After Hospital Discharge

Yael L. Maxwell

April 03, 2015

News Daily News

Study of STEMI Care in China Exposes Crucial Treatment Gaps

L.A. McKeown

June 27, 2014

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

L.A. McKeown

March 20, 2014

Advertisement

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

January 2021 News Roundup

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Acute MI Quality Improvement Program Fails in India, but Researchers See Bright Side

Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

High-Risk Acute MI Patients Less Likely to Stay on Guideline-Recommended Therapies After Hospital Discharge

Study of STEMI Care in China Exposes Crucial Treatment Gaps

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content